Regulatory Updates
Sep 8, 2026•1 min read
FDA Approves FLUMAZENIL (ANDA076955) for Intravenous Use
The FDA has approved the injectable drug FLUMAZENIL (application ANDA076955) from Fresenius Kabi USA, available in two IV strengths.
Regulatory Updates
Sep 8, 2026•1 min read
FDA Approves ANDA076589 for FLUMAZENIL Injectable Products
FDA approved ANDA076589 submitted by Dr Reddys, covering two injectable FLUMAZENIL products, both listed with discontinued marketing status.